logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Manabu Morimoto

Yokohama City University Medical Center
H指数:42
被引数:8,212

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nivolumab Plus Ipilimumab for Unresectable Hepatocellular Carcinoma in Early Real-World Clinical Practice: A Multicenter Analysis of Efficacy and Safety

纳武利尤单抗联合伊匹木单抗治疗不可切除肝细胞癌在早期真实世界临床实践中的疗效与安全性：一项多中心分析

Cancers
IF4.4
2026-08-280
OA
Hironao Okubo; Teppei Matsui; Makoto Chuma; Akihiro Funaoka; Haruki Uojima; Satoshi Narahara; Masahiro Kobayashi; Yuwa Ando; Tsunamasa Watanabe; Taito Fukushima; Satoshi Kobayashi; Katsuharu Hirano; Kota Tsuruya; Tatehiro Kagawa; Shuichiro Iwasaki; Hisashi Hidaka; Hidenari Nagai; Yasuhito Tanaka; Shin Maeda; Manabu Morimoto
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab

不可切除的肝细胞癌接受阿替利珠单抗联合贝伐珠单抗治疗后的三年总生存率

Hepatology International
IF6.1
2025-08-280
PRE
Masatsugu Ohara; Goki Suda; Risako Kohya; Yutaka Yasui; Kaoru Tsuchiya; Masayuki Kurosaki; Joji Tani; Shinya Maekawa; Nobuyuki Enomoto; Makoto Chuma; Manabu Morimoto; Shun Kaneko; Mina Nakagawa; Yasuhiro Asahina; Atsumasa Komori; Yuki Kugiyama; Masaru Baba; Akihisa Nakamura; Jun Ito; Ren Yamada; Shunichi Hosoda; Yoshiya Yamamoto; Sonoe Yoshida; Takuya Sho; Takashi Sasaki; Tomoka Yoda; Akimitsu Meno; Naohiro Yasuura; Qingjie Fu; Zijian Yang; Osamu Maehara; Shunsuke Ohnishi; Yoshimasa Tokuchi; Takashi Kitagataya; Naoki Kawagishi; Masato Nakai; Koji Ogawa; Naoya Sakamoto
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma
HEPATOLOGY INTERNATIONAL
IF6.1
2024-07-040
PRE
Chuma, Makoto; Uojima, Haruki; Toyoda, Hidenori; Hiraoka, Atsushi; Arase, Yoshitake; Atsukawa, Masanori; Itokawa, Norio; Okubo, Tomomi; Tada, Toshifumi; Numata, Kazushi; Morimoto, Manabu; Sugimori, Makoto; Nozaki, Akito; Iwasaki, Shuichiro; Yasuda, Satoshi; Koshiyama, Yuichi; Mishima, Yusuke; Tsuruya, Kota; Tokoro, Chikako; Miura, Yuki; Hidaka, Hisashi; Kumada, Takashi; Kusano, Chika; Kagawa, Tatehiro; Maeda, Shin
Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child-Pugh A category: A multicenter study

仑伐替尼联合射频消融序贯治疗可为不可切除、处于中期且肝功能分级为Child-Pugh A级的肝细胞癌患者带来生存获益：一项多中心研究

HEPATOLOGY RESEARCH
IF3.4
2024-07-020
PRE
Zhang, Ying; Numata, Kazushi; Imajo, Kento; Uojima, Haruki; Funaoka, Akihiro; Komiyama, Satoshi; Ogushi, Katsuaki; Chuma, Makoto; Irie, Kuniyasu; Kokubu, Shigehiro; Yoneda, Masato; Kobayashi, Takashi; Hidaka, Hisashi; Fukushima, Taito; Kobayashi, Satoshi; Morimoto, Manabu; Kagawa, Tatehiro; Hattori, Nobuhiro; Watanabe, Tsunamasa; Iwase, Shigeru; Maeda, Shin
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study

卡博替尼在日本晚期肝细胞癌患者中的应用: 一项多中心II期研究的最终结果

HEPATOLOGY RESEARCH
IF3.4
2023-01-234
OAAI
Kato, Naoya; Kudo, Masatoshi; Tsuchiya, Kaoru; Hagihara, Atsushi; Numata, Kazushi; Aikata, Hiroshi; Inaba, Yoshitaka; Kondo, Shunsuke; Motomura, Kenta; Okano, Naohiro; Ikeda, Masafumi; Morimoto, Manabu; Kuroda, Shingo; Kimura, Akiko
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis

在早期临床实践中，阿特珠单抗联合贝伐单抗治疗不可切除的肝细胞癌患者的安全性和有效性: 多中心分析

HEPATOLOGY RESEARCH
IF3.4
2021-11-3037
PRE
Chuma, Makoto; Uojima, Haruki; Hattori, Nobuhiro; Arase, Yoshitaka; Fukushima, Taito; Hirose, Shunji; Kobayashi, Satoshi; Ueno, Makoto; Tezuka, Shun; Iwasaki, Shuichiro; Wada, Naohisa; Kubota, Kousuke; Tsuruya, Kota; Shimma, Yoshimasa; Hiroki, Ikeda; Takuya, Ehira; Tokoro, Chikako; Iwase, Shigeru; Miura, Yuki; Moriya, Satoshi; Watanabe, Tsunamasa; Hidaka, Hisashi; Morimoto, Manabu; Numata, Kazushi; Kusano, Chika; Kagawa, Tatehiro; Maeda, Shin
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)

雷莫昔单抗治疗中期肝细胞癌和甲胎蛋白升高患者: 两项3期研究 (REACH和REACH-2) 的汇总结果

LIVER CANCER
IF9.1
2021-07-1214
OAAI
Kudo, Masatoshi; Finn, Richard S.; Morimoto, Manabu; Rau, Kun-Ming; Ikeda, Masafumi; Yen, Chia-Jui; Galle, Peter R.; Llovet, Josep M.; Daniele, Bruno; Lim, Ho Yeong; McIlwain, David W.; Yoshikawa, Reigetsu; Nakamura, Kenichi; Liang, Kun; Wang, Chunxiao; Abada, Paolo; Widau, Ryan C.; Zhu, Andrew X.
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis
HEPATOLOGY RESEARCH
IF3.4
2021-01-0527
PREAI
Chuma, Makoto; Uojima, Haruki; Hiraoka, Atsushi; Kobayashi, Satoshi; Toyoda, Hidenori; Tada, Toshifumi; Hidaka, Hisashi; Iwabuchi, Shogo; Numata, Kazushi; Itobayashi, Ei; Itokawa, Norio; Kariyama, Kazuya; Ohama, Hideko; Hattori, Nobuhiro; Hirose, Shunji; Shibata, Hiroshi; Tani, Joji; Imai, Michitaka; Tajiri, Kazuto; Moriya, Satoshi; Wada, Naohisa; Iwasaki, Shuitirou; Fukushima, Taito; Ueno, Makoto; Yasuda, Satoshi; Atsukawa, Masanori; Nouso, Kazuhiro; Fukunishi, Shinya; Watanabe, Tsunamasa; Ishikawa, Toru; Nakamura, Shinichiro; Morimoto, Manabu; Kagawa, Tatehiro; Sakamoto, Michiie; Kumada, Takashi; Maeda, Shin

研究方向

暂未获取到该数据
K
Kazushi Numata
H 指数:50论文数:345被引数:1.2万
K
Katsuaki Tanaka
H 指数:49论文数:243被引数:7,551
S
Shin Maeda
H 指数:66论文数:859被引数:2.5万
S
Satoshi Kobayashi
H 指数:40论文数:346被引数:4,982
M
Masaaki Kondo
H 指数:28论文数:127被引数:2,169
M
Makoto Ueno
H 指数:45论文数:570被引数:1.0万
H
Hisashi Hidaka
H 指数:63论文数:385被引数:1.6万
M
Masatoshi Kudo
H 指数:143论文数:2,840被引数:12.4万
T
Takuji Okusaka
H 指数:99论文数:952被引数:5.3万
T
Taito Fukushima
H 指数:18论文数:72被引数:766